Ubs Group Ag Harmony Biosciences Holdings, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 235,268 shares of HRMY stock, worth $8.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235,268

Previous 95,893 145.34%

Holding current value

$8.3 Million

Previous $3.83 Million 111.36%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $4.44 Million - $5.78 Million	139,375 Added 145.34%	235,268 $8.1 Million
Q3 2024 Nov 14, 2024	BUY	$30.0 - $39.95 $1.22 Million - $1.62 Million	40,593 Added 73.41%	95,893 $3.83 Million
Q2 2024 Aug 13, 2024	SELL	$28.81 - $33.01 $1.68 Million - $1.92 Million	-58,177 Reduced 51.27%	55,300 $1.67 Million
Q1 2024 May 13, 2024	BUY	$29.93 - $35.06 $2.07 Million - $2.43 Million	69,189 Added 156.23%	113,477 $3.81 Million
Q4 2023 Feb 09, 2024	BUY	$19.2 - $33.78 $556,128 - $978,437	28,965 Added 189.03%	44,288 $1.43 Million
Q3 2023 Nov 09, 2023	SELL	$31.89 - $39.03 $1.41 Million - $1.72 Million	-44,174 Reduced 74.25%	15,323 $502,000
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $1.2 Million - $1.48 Million	39,503 Added 197.57%	59,497 $2.09 Million
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $345,791 - $605,359	11,227 Added 128.06%	19,994 $652,000
Q4 2022 Feb 08, 2023	BUY	$45.4 - $60.91 $381,405 - $511,704	8,401 Added 2295.36%	8,767 $483,000
Q3 2022 Nov 10, 2022	SELL	$42.06 - $55.45 $41,849 - $55,172	-995 Reduced 73.11%	366 $16,000
Q2 2022 Aug 10, 2022	SELL	$33.54 - $52.15 $317,623 - $493,860	-9,470 Reduced 87.43%	1,361 $66,000
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $406,793 - $627,620	-12,275 Reduced 53.12%	10,831 $527,000
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $169,359 - $218,144	4,968 Added 27.39%	23,106 $986,000
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $243,960 - $366,795	-9,500 Reduced 34.37%	18,138 $695,000
Q2 2021 Aug 13, 2021	BUY	$25.96 - $33.44 $532,076 - $685,386	20,496 Added 286.98%	27,638 $781,000
Q1 2021 May 12, 2021	SELL	$27.56 - $40.37 $158,993 - $232,894	-5,769 Reduced 44.68%	7,142 $236,000
Q4 2020 Feb 11, 2021	SELL	$31.74 - $51.34 $288,484 - $466,629	-9,089 Reduced 41.31%	12,911 $467,000
Q3 2020 Nov 12, 2020	BUY	$30.96 - $44.39 $681,120 - $976,580	22,000 New	22,000 $746,000

Others Institutions Holding HRMY

# of Institutions

255

Shares Held

46.7M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.09B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account